XIX International AIDS Conference


SUSA22 New Frontiers in NIH AIDS Research
  Non-Commercial Satellite
Venue: Session Room 6
Time: 22.07.2012, 11:15 - 13:15
Chair: Jack Whitescarver, United States
Organiser: U.S. National Institutes of Health (NIH)
 
 
What are the biggest research challenges ahead in the effort to turn the tide against AIDS? How close are we to developing effective microbicides or vaccines? And is a cure for HIV infection really possible? This interative satellite with leading researchers from the U.S. National Institutes of Health (NIH) will outline the most important advances and challenges in AIDS research to date, including efforts to develop: *Better methods to prevent, identify and treat HIV and its co-infections, malignancies and complications *Improved biomedical and behavioral prevention tools, including Treatment as Prevention, microbicides, pre-exposure prophylaxis (PrEP) and vaccines *Strategies to understand the factors that affect HIV risk, treatment outcomes, and disease progression among different populations *New treatment and prevention strategies for substance users *Approaches to overcome drug resistance and treatment failure and to eradicate persistent HIV viral reservoirs, that may one day lead to a cure
Webcast provided by The Kaiser Family Foundation

11:15

Powerpoint
Welcome


J. Whitescarver, United States

11:20

Powerpoint
The NIH: Turning Discovery into Health


F. Collins, United States

11:30

Powerpoint
NIAID HIV/AIDS Research: Introduction and Overview


A. Fauci, United States

11:35

Powerpoint
NIAID AIDS Research: Achievements and Challenges


C. Dieffenbach, United States

11:50

Powerpoint
Understanding Neuro-AIDS and Implications for the Cure


A. Nath, United States

12:05

Powerpoint
Advances in Treating and Preventing HIV in Substances Users


N. Volkow, United States

12:20

Powerpoint
New Challenges in HIV-defining and Non-defining Malignancies


R. Yarchoan, United States

12:35

Powerpoint
Panel Discussion: Implications of Scientific Advances for Populations at Risk: Perspectives from Researchers, Clinicians, and the Community


V. Cargill, United States
B. Eldadah, United States
M. Harrington, United States
B. Kapogiannis, United States

12:35
Panel Discussion: Implications of Scientific Advances for Populations at Risk: Perspectives from Researchers, Clinicians, and the Community


G. Brown, United States

12:55
Questions and Answers



Powerpoints presentations
Welcome - Jack Whitescarver

The NIH: Turning Discovery into Health - Francis Collins

NIAID HIV/AIDS Research: Introduction and Overview - Anthony Fauci

NIAID AIDS Research: Achievements and Challenges - Carl W. Dieffenbach

Understanding Neuro-AIDS and Implications for the Cure - A. Nath

Advances in Treating and Preventing HIV in Substances Users - Nora Volkow

New Challenges in HIV-defining and Non-defining Malignancies - R. Yarchoan

Panel Discussion: Implications of Scientific Advances for Populations at Risk: Perspectives from Researchers, Clinicians, and the Community -



Rapporteur report

Track B report by Jose R Arribas


SUSA22. New Frontiers in NIH AIDS Research. SUSA22. (Non-Commercial Satellite)

This session was a very interesting overview of the priorities of NIH-funded research (more than 3 billion dollars for 2012). In 2012 this budget would be distributed:

Vaccines: 29.9%

Therapeutics: 26.2%

Etiology and Pathogenesis: 20.6%

Natural History and Epidemiology: 10.2%

Microbicides: 6%

Training & Infrastructure: 4.5%

Behavioral research: 1.8%

Information dissemination: 0.8%

 

The exciting areas of research that the speakers reviewed were:

Current key scientific challenges and major priorities:

  1. Vaccine
    1. Follow up on RV144 result*
    2. Advance broadly neutralizing antibodies into proof of concept
  2. Cure
  3. Understanding Neuro-AIDS and Implications for the Cure
  4. HIV, AIDS and substance abuse: the goal seek, test, treat and retain

* Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209–2220.




   

    The organizers reserve the right to amend the programme.


Contact Us | Site map © 2012 International AIDS Society